2 options
Examining concerns regarding FDA's proposed changes to generic drug labeling : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, April 1, 2014.
Connect to full text Available online
View online- Format:
- Book
- Government document
- Author/Creator:
- United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author.
- Language:
- English
- Subjects (All):
- Generic drugs--Labeling--United States.
- Generic drugs.
- Drugs--Safety regulations--United States.
- Drugs.
- Warning labels--Government policy--United States.
- Warning labels.
- Drugs--Safety regulations.
- United States.
- Genre:
- Legislative hearings
- Legislative hearings.
- Physical Description:
- 1 online resource (v, 146 pages)
- Place of Publication:
- Washington : U.S. Government Publishing Office, 2016.
- Notes:
- Title from title screen (viewed on March 31, 2016).
- Paper version available for sale by the Superintendent of Documents, U.S. Government Publishing Office.
- Includes bibliographical references.
- "Serial No. 113-132."
- Other Format:
- Print version: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health. Examining concerns regarding FDA's proposed changes to generic drug labeling
- Microfiche version: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health. Examining concerns regarding FDA's proposed changes to generic drug labeling
- OCLC:
- 945734630
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.